Dermatology Thesis Topics

Dermatology thesis topics represent a clinically diverse and scientifically productive area within health thesis topics, drawing graduate students at American universities into a discipline that addresses the diagnosis, treatment, and prevention of diseases affecting the skin, hair, nails, and mucous membranes — the largest organ system of the human body. Dermatology encompasses inflammatory skin diseases, skin cancer, infectious dermatology, autoimmune conditions, cosmetic dermatology, pediatric dermatology, and the growing fields of dermato-oncology, immunodermatology, and dermatological health disparities. As biologic therapies transform outcomes for American patients with atopic dermatitis and psoriasis, skin cancer incidence continues rising, and dermatological care access disparities widen across American communities, the research questions animating dermatology thesis topics have never been more scientifically productive or clinically consequential.

Dermatology Thesis Topics and Research Areas

The discipline of dermatology research spans molecular immunology, clinical trial methodology, epidemiology, health services research, and the translational sciences connecting laboratory discoveries about skin biology to novel therapeutic approaches for American patients with skin disease. Graduate students pursuing dermatology thesis topics engage with immunological assays characterizing skin inflammation mechanisms, randomized controlled trials of biologic therapies, cancer registry analyses of melanoma incidence trends, qualitative studies of patient experience with chronic skin disease, and implementation science frameworks for improving dermatological care access across American communities. The 200 dermatology thesis topics organized below into 10 thematic categories are designed to be research-ready at American dermatology residency research programs, skin biology doctoral programs, and academic medical centers with comprehensive dermatological research infrastructure.

1. Inflammatory Skin Diseases

Inflammatory skin diseases — encompassing atopic dermatitis, psoriasis, contact dermatitis, hidradenitis suppurativa, and lichen planus — collectively represent the most prevalent category of dermatological conditions in the United States, with millions of Americans experiencing significant disability, psychological burden, and reduced quality of life from chronic inflammatory skin conditions. This category of dermatology thesis topics addresses the immunological mechanisms driving skin inflammation, the comparative effectiveness of escalating therapeutic options, and the health services research questions surrounding the delivery of evidence-based inflammatory skin disease care across American dermatology practices. Graduate students contribute to understanding both the biological basis of skin inflammation and the clinical innovations needed to improve outcomes for Americans with these often-undertreated conditions.

1. Investigating the dupilumab long-term effectiveness and safety in American adults with moderate-to-severe atopic dermatitis beyond two years of continuous treatment using real-world registry data
2. Analyzing the tralokinumab versus dupilumab comparative effectiveness for atopic dermatitis control and patient-reported outcome improvement in American adults with inadequate response to topical therapy
3. Developing a treat-to-target algorithm for atopic dermatitis management in American adults incorporating Eczema Area and Severity Index, pruritus numerical rating scale, and patient global assessment thresholds
4. Characterizing the atopic dermatitis skin microbiome dysbiosis patterns — including Staphylococcus aureus overabundance — and their relationship to disease severity and biologic therapy response in American patients
5. Investigating the JAK inhibitor upadacitinib and abrocitinib comparative effectiveness and safety profile for American adults with severe atopic dermatitis and inadequate dupilumab response
6. Analyzing the psoriasis biologic therapy drug survival rates and discontinuation reasons across tumor necrosis factor inhibitors, interleukin-17 inhibitors, and interleukin-23 inhibitors in American dermatology practice settings
7. Developing a psoriatic arthritis screening and rheumatology referral program for American dermatology practices and evaluating its impact on early arthritis detection and joint damage prevention
8. Characterizing the hidradenitis suppurativa disease burden — including wound care requirements, employment impairment, and depression — in American adults and evaluating adalimumab and secukinumab treatment effectiveness
9. Investigating the contact allergen sensitization patterns in American adults with occupational and non-occupational contact dermatitis using patch test data from North American Contact Dermatitis Group surveillance
10. Analyzing the racial and ethnic disparities in atopic dermatitis clinical presentation — including lichenification patterns and affected body sites — and biologic therapy access in American patients
11. Developing a teledermatology-assisted atopic dermatitis management program for American pediatric primary care practices in dermatology shortage areas and evaluating its clinical outcome effectiveness
12. Characterizing the dupilumab effect on atopic dermatitis comorbidities — including asthma, allergic rhinitis, and eosinophilic esophagitis — in American adults with atopic march phenotype
13. Investigating the itch neurobiology — including type 2 cytokine effects on sensory neurons — and nemolizumab anti-IL-31 receptor therapy effectiveness for pruritus reduction in American atopic dermatitis patients
14. Analyzing the psoriasis cardiovascular comorbidity burden and its modification through biologic therapy in American adults using electronic health record cohort methodology with matched controls
15. Developing a patient decision aid for biologic therapy selection in American adults with moderate-to-severe psoriasis and evaluating its impact on treatment choice concordance with patient preferences
16. Characterizing the lichen planus clinical variants — including oral, nail, and vulvar disease — and their management outcomes in American dermatology and mucosal disease clinic populations
17. Investigating the topical JAK inhibitor ruxolitinib and delgocitinib effectiveness for mild-to-moderate atopic dermatitis in American adults and children using pooled clinical trial and real-world data
18. Analyzing the hidradenitis suppurativa surgical management outcomes — including wide local excision and laser-assisted hair removal — in American adults across different Hurley staging categories
19. Developing a multidisciplinary inflammatory skin disease clinic model for American academic dermatology programs and evaluating its impact on biologic therapy initiation rates and patient-reported outcomes
20. Characterizing the atopic dermatitis sleep disruption burden and its bidirectional relationship with disease severity in American children using actigraphy and validated sleep questionnaire methodology

2. Skin Cancer and Melanoma

Skin cancer is the most common cancer in the United States — with more than five million cases of non-melanoma skin cancer and approximately one hundred thousand new melanoma diagnoses annually — making skin cancer research one of the most impactful and actively funded areas of American dermatology. This category of dermatology thesis topics addresses melanoma biology and immunotherapy, basal cell carcinoma and squamous cell carcinoma management, dermoscopy and early detection, Mohs micrographic surgery outcomes, and the public health strategies for reducing American skin cancer burden through primary and secondary prevention.

21. Investigating the adjuvant pembrolizumab versus nivolumab comparative effectiveness and safety for American adults with resected high-risk stage three melanoma using propensity-matched real-world outcomes data
22. Analyzing the tumor mutational burden and PD-L1 expression associations with checkpoint inhibitor response durability in American adults with advanced melanoma across different BRAF mutation status categories
23. Developing a dermoscopy training and quality assurance program for American primary care physicians and evaluating its impact on appropriate melanoma referral rates and benign lesion biopsy reduction
24. Characterizing the total body skin examination performance of artificial intelligence-assisted dermoscopy compared to board-certified American dermatologists for melanoma and dysplastic nevus detection
25. Investigating the vismodegib and sonidegib hedgehog pathway inhibitor effectiveness and resistance mechanisms for locally advanced and metastatic basal cell carcinoma in American patients
26. Analyzing the cutaneous squamous cell carcinoma immunotherapy cemiplimab effectiveness in American adults with locally advanced and metastatic disease using clinical trial and real-world registry data
27. Developing a high-risk squamous cell carcinoma surveillance program for American solid organ transplant recipients and evaluating its cancer detection yield and early-stage diagnosis improvement
28. Characterizing the Mohs micrographic surgery appropriate use criteria adherence patterns and clinical outcome quality across American dermatological surgery practices using national claims and registry data
29. Investigating the melanoma family history genetic counseling and surveillance program effectiveness in American adults with two or more first-degree relatives with melanoma
30. Analyzing the sunscreen use behavior determinants and ultraviolet protection program effectiveness in American adolescents using theory-based behavioral intervention methodology
31. Developing a skin cancer early detection program for American adults with albinism — a population at extremely high skin cancer risk — and evaluating its screening frequency and protective intervention outcomes
32. Characterizing the actinic keratosis treatment modality comparative effectiveness — including liquid nitrogen, photodynamic therapy, and fluorouracil — for field cancerization management in American adults with extensive sun damage
33. Investigating the dermoscopic features and reflectance confocal microscopy patterns that predict malignant transformation in American adults with dysplastic nevi under surveillance
34. Analyzing the Merkel cell carcinoma avelumab and pembrolizumab immunotherapy outcomes and recurrence patterns in American patients with advanced disease using multicenter registry methodology
35. Developing a workplace ultraviolet radiation protection program for American outdoor workers — including construction, agriculture, and landscaping — and evaluating its sunscreen use and skin cancer screening outcomes
36. Characterizing the melanoma racial disparities in stage at diagnosis and survival outcomes between American Black and white patients and evaluating the access, awareness, and biological factors contributing to worse outcomes
37. Investigating the BRAF plus MEK inhibitor combination therapy resistance mechanisms and subsequent immunotherapy sequencing outcomes in American adults with BRAF-mutant metastatic melanoma
38. Analyzing the cost-effectiveness of different skin cancer screening strategies for American adults across different risk categories using decision analysis modeling methodology
39. Developing a patient self-examination education program for American adults with multiple dysplastic nevi and evaluating its dermoscopy-guided self-monitoring accuracy and melanoma detection effectiveness
40. Characterizing the primary cutaneous lymphoma — including mycosis fungoides and Sézary syndrome — epidemiology, diagnostic delays, and brentuximab vedotin treatment outcomes in American dermatology-hematology programs

3. Autoimmune and Blistering Skin Diseases

Autoimmune skin diseases — including pemphigus vulgaris, bullous pemphigoid, dermatomyositis, lupus erythematosus, and morphea — represent a diverse category of potentially life-threatening dermatological conditions in which the immune system attacks skin structures, requiring immunosuppressive therapy that carries significant toxicity risks for American patients. This category of dermatology thesis topics addresses the immunological mechanisms of autoimmune skin disease, novel therapeutic approaches including rituximab and emerging targeted therapies, and the complex management challenges of balancing disease control with treatment toxicity in American dermatology practices.

41. Investigating the rituximab versus mycophenolate mofetil comparative effectiveness and relapse prevention in American adults with pemphigus vulgaris using a randomized controlled trial design
42. Analyzing the bullous pemphigoid anti-BP180 and anti-BP230 autoantibody titer dynamics as disease activity biomarkers and treatment response predictors in American dermatology clinic populations
43. Developing a dermatomyositis myositis-specific autoantibody panel interpretation guideline for American dermatologists and evaluating its impact on malignancy screening appropriateness and immunosuppression selection
44. Characterizing the cutaneous lupus erythematosus clinical subtypes, treatment response patterns, and systemic lupus erythematosus progression risk in American patients using multicenter lupus registry data
45. Investigating the intravenous immunoglobulin effectiveness for refractory bullous pemphigoid and its corticosteroid-sparing potential in American adults with high diabetes and infection risk
46. Analyzing the neonatal lupus syndrome — including congenital heart block — maternal autoantibody profile associations and recurrence risk counseling in American pregnant women with anti-Ro/SSA antibodies
47. Developing a morphea — localized scleroderma — severity assessment tool for American pediatric and adult dermatology populations and evaluating methotrexate treatment effectiveness for moderate to severe disease
48. Characterizing the IgA dermatoses — including dermatitis herpetiformis and linear IgA bullous dermatosis — clinical features, gluten-free diet response, and dapsone treatment outcomes in American patients
49. Investigating the efgartigimod neonatal Fc receptor-targeted therapy effectiveness for pemphigus vulgaris and bullous pemphigoid treatment in American adults with moderate to severe disease
50. Analyzing the systemic sclerosis cutaneous manifestation progression and immunosuppressive therapy outcomes in American adults with diffuse versus limited cutaneous systemic sclerosis
51. Developing a transition of care program for American adolescents with autoimmune skin diseases moving from pediatric to adult dermatology and evaluating treatment continuity and disease control outcomes
52. Characterizing the epidermolysis bullosa clinical spectrum — including dystrophic, junctional, and Kindler variants — wound care program outcomes, and gene therapy trial enrollment patterns in American centers
53. Investigating the eosinophilic granulomatosis with polyangiitis cutaneous manifestations and mepolizumab treatment effectiveness in American adults with systemic involvement
54. Analyzing the skin-directed versus systemic therapy comparative outcomes for moderate-to-severe plaque psoriasis in American adults with psoriatic arthritis using rheumatology-dermatology collaborative registry data
55. Developing a multidisciplinary autoimmune blistering disease clinic for American academic dermatology programs and evaluating its impact on treatment optimization and hospitalization reduction

4. Acne, Rosacea, and Follicular Disorders

Acne vulgaris and rosacea are among the most prevalent dermatological conditions affecting American adults and adolescents — with acne affecting approximately fifty million Americans annually and rosacea affecting approximately fourteen million — while follicular disorders including hidradenitis suppurativa, folliculitis decalvans, and dissecting cellulitis represent less common but significantly disabling conditions. This category of dermatology thesis topics addresses the pathophysiology, treatment optimization, and quality of life dimensions of these highly prevalent and psychologically impactful skin conditions across American dermatology practice settings.

56. Investigating the oral sarecycline versus doxycycline comparative effectiveness and antibiotic resistance profile for moderate-to-severe inflammatory acne vulgaris in American adolescents and adults
57. Analyzing the isotretinoin treatment outcome predictors — including baseline disease severity, prior treatment history, and pharmacogenomic factors — and relapse rates in American adults with severe nodulocystic acne
58. Developing a standardized acne severity grading and treatment algorithm for American primary care practices and evaluating its impact on appropriate antibiotic prescribing and dermatology referral patterns
59. Characterizing the post-inflammatory hyperpigmentation burden and treatment outcomes in American adults with skin of color following acne resolution using validated colorimetric assessment methodology
60. Investigating the low-dose doxycycline versus topical metronidazole versus brimonidine comparative effectiveness for rosacea subtype-specific management in American adults
61. Analyzing the gut microbiome dysbiosis associations and probiotic supplementation effects on rosacea severity in American adults using matched case-control and intervention study methodology
62. Developing a rosacea trigger identification program for American adults and evaluating the effectiveness of individualized trigger avoidance counseling on symptom frequency and severity
63. Characterizing the acne vulgaris psychological burden — including depression, social anxiety, and body dysmorphic disorder risk — and its relationship to disease severity and treatment response in American adolescents
64. Investigating the benzoyl peroxide and adapalene fixed-dose combination effectiveness and microbiome resistance impact compared to antibiotic-containing regimens for American adults with moderate inflammatory acne
65. Analyzing the hormonal therapy — including combined oral contraceptives and spironolactone — effectiveness for adult female acne in American women and evaluating prescribing pattern determinants
66. Developing a teledermatology acne management program for American adolescents in school-based health settings and evaluating its clinical outcome effectiveness and antibiotic stewardship impact
67. Characterizing the azelaic acid gel and foam formulation effectiveness for post-inflammatory erythema and hyperpigmentation following acne treatment in American adults with Fitzpatrick skin type III-VI
68. Investigating the folliculitis decalvans and dissecting cellulitis treatment outcomes with doxycycline, rifampicin combinations, and laser hair removal in American hair disorder clinic populations
69. Analyzing the acne vulgaris treatment adherence predictors and telehealth monitoring effectiveness for improving medication persistence in American adolescents in primary care settings
70. Developing a national acne antibiotic stewardship program for American dermatology practices and evaluating its impact on long-term oral antibiotic prescribing duration and antibiotic resistance monitoring

5. Hair and Nail Disorders

Hair and nail disorders — including alopecia areata, androgenetic alopecia, nail psoriasis, onychomycosis, and traction alopecia — represent conditions that profoundly impact the quality of life and self-image of affected Americans, with important research questions about the immunobiology of hair follicle disorders, novel pharmacological treatments, and the health equity dimensions of hair disorder care in American patients with diverse hair types and textures. This category of dermatology thesis topics addresses the biology, clinical management, and patient experience dimensions of hair and nail disease across American dermatology practices.

71. Investigating the JAK inhibitor baricitinib and ritlecitinib long-term effectiveness and relapse patterns following treatment discontinuation in American adults with moderate-to-severe alopecia areata
72. Analyzing the alopecia areata psychological burden — including depression, anxiety, and quality of life impairment — and its relationship to disease extent and treatment response in American adult and adolescent populations
73. Developing a traction alopecia prevention education program for American Black girls and women using culturally tailored hairstyling practice counseling in dermatology and primary care settings
74. Characterizing the frontal fibrosing alopecia epidemiology, clinical associations, and hydroxychloroquine versus 5-alpha reductase inhibitor treatment comparative outcomes in American women
75. Investigating the platelet-rich plasma injection effectiveness for androgenetic alopecia in American adults across different Norwood-Hamilton and Ludwig classification categories using sham-controlled trial methodology
76. Analyzing the oral minoxidil low-dose effectiveness and cardiovascular safety profile for androgenetic alopecia in American women and men across different age and cardiovascular risk categories
77. Developing a dermoscopy-based hair and scalp examination protocol for American dermatologists and evaluating its diagnostic accuracy for distinguishing alopecia areata from other scarring and non-scarring alopecia subtypes
78. Characterizing the lichen planopilaris and frontal fibrosing alopecia association with systemic autoimmune conditions and thyroid disease in American women using electronic health record cohort methodology
79. Investigating the nail psoriasis severity assessment and biologic therapy response — including secukinumab and ixekizumab — in American adults with isolated nail psoriasis without skin involvement
80. Analyzing the onychomycosis treatment outcomes with oral terbinafine versus efinaconazole topical therapy and recurrence prevention strategies in American adults with dermatophyte nail infection

6. Pediatric Dermatology

Pediatric dermatology addresses the unique dermatological conditions of infants, children, and adolescents — including birthmarks, infantile hemangiomas, genodermatoses, and the pediatric manifestations of inflammatory skin diseases — making this a specialized category of dermatology thesis topics at American children’s hospital dermatology programs and academic pediatric dermatology centers. Research here encompasses the biology of skin development, the management of complex pediatric skin conditions, and the health systems challenges of providing dermatological expertise to American children in a specialty with significant access disparities.

81. Investigating the propranolol versus timolol comparative effectiveness and treatment duration optimization for infantile hemangioma involution in American infants across different hemangioma subtypes and locations
82. Analyzing the genodermatosis — including ichthyosis, epidermolysis bullosa, and ectodermal dysplasia — quality of life burden and multidisciplinary care program outcomes in American children using validated pediatric quality of life instruments
83. Developing a telemedicine pediatric dermatology consultation program for American rural children’s hospitals and evaluating its diagnostic accuracy and treatment recommendation quality compared to in-person evaluation
84. Characterizing the pediatric psoriasis biologic therapy effectiveness and safety — including secukinumab, ixekizumab, and risankizumab — in American children and adolescents using clinical trial and real-world data
85. Investigating the molluscum contagiosum treatment outcomes — comparing cantharidin, imiquimod, and watchful waiting — in American children across different clinical settings and patient preference contexts
86. Analyzing the atopic dermatitis prevention strategies in American infants at high genetic risk using early emollient therapy and microbiome modulation interventions
87. Developing a nevus surveillance protocol for American children with multiple congenital melanocytic nevi and evaluating imaging-based monitoring versus dermoscopy for melanoma transformation detection
88. Characterizing the mastocytosis clinical spectrum — from urticaria pigmentosa to systemic mastocytosis — and anaphylaxis risk management in American children using multicenter pediatric mastocytosis registry data
89. Investigating the acne vulgaris biopsychosocial impact and isotretinoin prescribing patterns in American adolescents across different dermatology practice settings and socioeconomic groups
90. Analyzing the pediatric teledermatology program effectiveness in American school-based health clinics for managing common skin conditions and reducing unnecessary emergency department dermatology visits

7. Dermatology Health Disparities and Access

Dermatology health disparities represent one of the most significant equity challenges in American medicine — with dermatology among the least racially diverse medical specialties, chronic skin diseases disproportionately affecting communities of color in ways that have been historically understudied in populations with diverse skin tones, and dermatology care access among the most difficult to obtain of any American specialty. This category of dermatology thesis topics examines the mechanisms and magnitude of dermatological health disparities, the adequacy of dermatological education for diverse skin tones, and the interventions that can promote equitable skin health across American communities.

91. Investigating the dermatology appointment wait time disparities across American patients with Medicaid versus commercial insurance and evaluating their relationship to advanced-stage skin cancer diagnosis rates
92. Analyzing the skin cancer clinical presentation differences across Fitzpatrick skin types in American patients and evaluating the diagnostic delay consequences for American patients of color with melanoma
93. Developing a community-based dermatology screening program for American underserved communities using teledermatology and trained community health worker skin examination and evaluating its early detection effectiveness
94. Characterizing the medical school dermatology curriculum representation of diverse skin tones in American medical education and evaluating its relationship to graduate diagnostic accuracy for skin disease in patients of color
95. Investigating the racial and ethnic disparities in biologic therapy prescription rates for atopic dermatitis and psoriasis in American commercial insurance and Medicaid populations
96. Analyzing the keloid and hypertrophic scar treatment access and outcome disparities in American patients of African descent compared to white patients across American dermatology practices
97. Developing a cultural competency training program for American dermatology residents focused on managing common skin conditions in patients with skin of color and evaluating its diagnostic skill impact
98. Characterizing the acne post-inflammatory hyperpigmentation treatment access and outcome disparities in American patients with Fitzpatrick skin types IV-VI in academic versus community dermatology settings
99. Investigating the teledermatology program reach and equity — including who initiates and completes teledermatology visits — in American safety-net health systems serving diverse low-income populations
100. Analyzing the dermatology workforce racial and gender diversity patterns and pipeline program effectiveness for increasing underrepresented minority dermatology resident recruitment across American programs

8. Dermatological Surgery and Procedural Dermatology

Dermatological surgery and procedural dermatology encompass Mohs micrographic surgery, laser surgery, cosmetic procedures, photodynamic therapy, and the surgical management of complex skin conditions — making this a technically specialized category of dermatology thesis topics at American dermatological surgery training programs and academic dermatology centers with comprehensive procedural capability. Research here addresses surgical technique outcomes, wound repair approaches, laser and energy device effectiveness, and the growing role of cosmetic dermatological procedures in American healthcare.

101. Investigating the Mohs micrographic surgery recurrence rates and cosmetic outcome quality for facial basal cell carcinoma across American dermatological surgery practices stratified by surgeon volume
102. Analyzing the sublative rejuvenation and fractional carbon dioxide laser effectiveness for post-acne scarring improvement in American adults across different Fitzpatrick skin types using standardized photographic assessment
103. Developing a wound closure technique selection guideline for American dermatological surgeons based on defect location, size, and patient factors and evaluating its cosmetic outcome and complication rate impact
104. Characterizing the botulinum toxin injection pattern optimization for glabellar, forehead, and periorbital rhytides in American adults and evaluating patient-reported satisfaction and adverse event patterns
105. Investigating the hyaluronic acid filler complication — including vascular occlusion and delayed inflammatory reaction — incidence and management outcomes in American cosmetic dermatology practices
106. Analyzing the photodynamic therapy protocol optimization — including aminolevulinic acid concentration, incubation time, and light source — for actinic keratosis field treatment in American adults with extensive sun damage
107. Developing a patient safety reporting system for cosmetic dermatological procedures in American office-based settings and evaluating its utility for identifying adverse event patterns and implementing preventive measures
108. Characterizing the nail surgery outcomes and complication rates for ingrown toenail correction, biopsy, and nail matrix procedures in American dermatological surgery practices
109. Investigating the pulsed dye laser effectiveness for port-wine birthmark lightening in American children and evaluating early treatment initiation advantages for long-term cosmetic outcomes
110. Analyzing the scar revision outcomes — including intralesional corticosteroid, 5-fluorouracil, and laser combinations — for hypertrophic and keloid scars in American patients across different Fitzpatrick skin types

9. Teledermatology and Digital Skin Health

Teledermatology has emerged as one of the most developed and evidence-based applications of telemedicine across medical specialties — with store-and-forward teledermatology enabling asynchronous specialist consultation for primary care providers managing patients with skin conditions in American underserved communities. This category of dermatology thesis topics addresses teledermatology program design and implementation, diagnostic accuracy, patient and provider experience, artificial intelligence-assisted dermatological diagnosis, and the equity implications of digital dermatological care for American patients across geographic and socioeconomic barriers.

111. Investigating the store-and-forward teledermatology diagnostic concordance with in-person dermatology examination across common inflammatory, infectious, and neoplastic skin conditions in American primary care referral programs
112. Analyzing the live-video teledermatology effectiveness for follow-up management of American adults with psoriasis and atopic dermatitis on biologic therapy compared to in-person clinic visits
113. Developing a direct-to-patient teledermatology program for American adults in rural communities without local dermatology access and evaluating its diagnostic quality and treatment initiation outcomes
114. Characterizing the artificial intelligence dermoscopy algorithm performance for melanoma detection and triage in American primary care teledermatology programs compared to dermatologist review
115. Investigating the smartphone-based skin disease application accuracy for common skin conditions in American consumers and evaluating the safety implications of inappropriate application-guided self-treatment
116. Analyzing the teledermatology program implementation barriers and facilitators in American federally qualified health centers using the Consolidated Framework for Implementation Research
117. Developing a teledermatology quality assurance framework for American health systems and evaluating its utility for monitoring diagnostic accuracy, treatment appropriateness, and patient safety outcomes
118. Characterizing the teledermatology image quality determinants — including lighting, resolution, and lesion positioning — and their relationship to diagnostic accuracy in American primary care referral programs
119. Investigating the patient satisfaction and technology acceptability of teledermatology visits across age, race, and socioeconomic groups in American health system populations using validated patient experience surveys
120. Analyzing the artificial intelligence convolutional neural network performance for classifying inflammatory versus infectious versus neoplastic skin conditions from clinical photographs in American dermatology archives

10. Dermatopharmacology and Topical Therapy

Dermatopharmacology addresses the unique pharmacological challenges of topical drug delivery — including penetration enhancement, vehicle formulation, and the pharmacokinetics of transcutaneous drug absorption — as well as the systemic pharmacology of immunosuppressive, biologic, and targeted therapies used in dermatological practice. This category of dermatology thesis topics encompasses topical drug development, biologic therapy pharmacology, drug-drug interactions in dermatological patients, and the pharmacoeconomics of high-cost dermatological biologics.

121. Investigating the topical roflumilast foam effectiveness for seborrheic dermatitis and scalp psoriasis in American adults and evaluating its PDE4 inhibition mechanism and steroid-sparing potential
122. Analyzing the calcineurin inhibitor versus low-potency corticosteroid comparative effectiveness for maintenance therapy of facial and intertriginous atopic dermatitis in American adults and children
123. Developing a topical corticosteroid potency selection and application frequency guideline for American primary care physicians and evaluating its impact on appropriate prescribing and adverse effect reduction
124. Characterizing the skin penetration enhancement approaches for improved transdermal delivery of biologics and large molecule therapeutics using microneedle and nanoparticle carrier systems
125. Investigating the crisaborole phosphodiesterase-4 inhibitor effectiveness and tolerability for mild-to-moderate atopic dermatitis in American infants and toddlers under two years of age
126. Analyzing the biosimilar adalimumab equivalence and patient acceptance for psoriasis and hidradenitis suppurativa treatment in American dermatology practices following reference product exclusivity expiration
127. Developing a pharmacovigilance program for systemic retinoid teratogenicity prevention — iPLEDGE program evaluation — in American women of childbearing age receiving isotretinoin
128. Characterizing the drug-induced skin reactions — including Stevens-Johnson syndrome and toxic epidermal necrolysis — epidemiology and outcome prediction in American hospital dermatology consultation services
129. Investigating the sunscreen formulation comparative effectiveness for ultraviolet A and B protection in American consumer sunscreen products and evaluating FDA sunscreen monograph compliance
130. Analyzing the biologic therapy drug-drug interaction profiles for American dermatology patients on multiple immunosuppressive therapies and evaluating their clinical significance for infection and vaccination safety

11. Skin Microbiome and Infectious Dermatology

Infectious dermatology addresses bacterial, fungal, viral, and parasitic infections of the skin — from common conditions including impetigo, tinea, and warts to serious infections including community-acquired methicillin-resistant Staphylococcus aureus and necrotizing fasciitis — while skin microbiome research is revolutionizing the understanding of how commensal skin bacteria interact with the immune system to maintain skin health or contribute to inflammatory disease. This category of dermatology thesis topics draws on microbiology, immunology, and infectious disease science to address the complex relationship between microorganisms and skin health in American populations.

131. Investigating the skin microbiome compositional changes and their relationship to atopic dermatitis severity, flare frequency, and biologic therapy response in American children using 16S rRNA sequencing methodology
132. Analyzing the community-acquired methicillin-resistant Staphylococcus aureus skin infection epidemiology and trimethoprim-sulfamethoxazole versus clindamycin comparative effectiveness in American emergency department populations
133. Developing a skin microbiome restoration therapy using Roseomonas mucosa or Staphylococcus hominis for atopic dermatitis management in American adults and evaluating its safety and clinical outcome effectiveness
134. Characterizing the tinea capitis dermatophyte species distribution and antifungal treatment response patterns in American children across different geographic regions and racial groups
135. Investigating the molluscum contagiosum epidemiology and natural history in American immunocompetent children and evaluating the comparative burden of no treatment versus active intervention approaches
136. Analyzing the varicella-zoster virus reactivation — herpes zoster — risk factors and recombinant zoster vaccine effectiveness in American adults with inflammatory skin diseases on immunosuppressive therapy
137. Developing a wound infection prevention protocol for American Mohs micrographic surgery centers and evaluating its impact on post-operative infection rates and antibiotic prophylaxis practices
138. Characterizing the Demodex folliculorum density patterns and their relationship to rosacea subtype, severity, and ivermectin cream treatment response in American adults
139. Investigating the cutaneous leishmaniasis clinical recognition and management in American travelers and military veterans returning from endemic regions and evaluating treatment outcome data
140. Analyzing the antifungal stewardship program effectiveness for reducing inappropriate systemic antifungal prescribing for onychomycosis in American primary care and dermatology settings

12. Psychodermatology

Psychodermatology addresses the bidirectional relationship between skin disease and psychological health — encompassing the psychiatric comorbidities of chronic skin conditions, the psychological distress generated by visible skin disease, and the psychocutaneous disorders in which psychological factors directly cause or perpetuate skin symptoms. This specialized category of dermatology thesis topics addresses an often-neglected dimension of dermatological care that profoundly influences American patients’ wellbeing, treatment adherence, and clinical outcomes.

141. Investigating the depression and anxiety prevalence and their bidirectional relationship with atopic dermatitis severity in American adults using longitudinal electronic health record cohort methodology
142. Analyzing the psoriasis stigma experiences and their psychological health and treatment adherence consequences in American adults across different disease severity levels using validated stigma assessment methodology
143. Developing an integrated dermatology and mental health care model for American academic dermatology clinics and evaluating its impact on psychological distress, treatment adherence, and skin disease control
144. Characterizing the body dysmorphic disorder prevalence and cosmetic procedure-seeking behavior in American dermatology cosmetic patients and evaluating appropriate screening and referral practices
145. Investigating the dermatitis artefacta and excoriation disorder clinical characteristics and cognitive behavioral therapy outcomes in American adults presenting to dermatology and psychiatry settings
146. Analyzing the isotretinoin treatment and depression risk relationship in American adolescents using a large-scale pharmacoepidemiological study with active comparator and new user design methodology
147. Developing a mindfulness-based intervention for American adults with chronic pruritus and evaluating its itch intensity reduction and quality of life improvement outcomes using a randomized trial design
148. Characterizing the vitiligo psychological burden — including depression, social anxiety, and quality of life impairment — and its modification through effective repigmentation therapy in American adults
149. Investigating the quality of life impact of visible birthmarks — including port-wine stains and congenital melanocytic nevi — on American children and adolescents and evaluating psychosocial support intervention effectiveness
150. Analyzing the skin-picking disorder and hair-pulling disorder relationship to obsessive-compulsive spectrum and their cognitive behavioral therapy response in American adults in dermatology settings

13. Occupational and Environmental Dermatology

Occupational and environmental dermatology addresses the skin diseases caused by workplace and environmental exposures — including occupational contact dermatitis, occupational acne and folliculitis, radiation-induced skin disease, and the dermatological consequences of chemical burns and toxic exposures — making this a practically important category of dermatology thesis topics with significant public health and workers’ compensation implications for American workers across high-exposure industries.

151. Investigating the occupational contact dermatitis incidence and allergen exposure patterns in American healthcare workers — particularly with latex, glutaraldehyde, and rubber accelerators — using patch test registry and occupational surveillance data
152. Analyzing the irritant contact dermatitis prevention effectiveness of barrier cream and glove use programs in American food processing and manufacturing workers with high-moisture skin exposure
153. Developing a return-to-work program for American workers disabled by occupational contact dermatitis and evaluating its occupational exposure reduction and skin healing outcome effectiveness
154. Characterizing the occupational acne and chloracne patterns in American workers with industrial chemical exposures including cutting oils, chlorinated naphthalenes, and polychlorinated biphenyls
155. Investigating the firefighter occupational dermatological hazard exposure — including combustion product carcinogens and PFAS from protective gear — and skin cancer risk in American fire service workers
156. Analyzing the agricultural worker pesticide-related dermatosis incidence and prevention program effectiveness in American farmworkers using occupational health monitoring and intervention methodology
157. Developing an occupational dermatosis reporting and compensation program evaluation for American workers and evaluating the adequacy of workers’ compensation frameworks for occupational skin disease
158. Characterizing the radiation dermatitis prevention and management practices for American interventional radiology and cardiology workers with chronic low-dose radiation hand exposure
159. Investigating the cosmetic and personal care product contact sensitization patterns and their relationship to ingredient labeling adequacy for American consumers with sensitive skin
160. Analyzing the COVID-19 pandemic personal protective equipment-related dermatoses — including pressure injuries, contact dermatitis, and acne mechanica — in American healthcare workers and evaluating preventive interventions

14. Cosmetic Dermatology and Aesthetic Medicine

Cosmetic dermatology and aesthetic medicine address the growing demand for appearance-enhancing procedures among American adults — including neurotoxin injections, dermal fillers, laser resurfacing, body contouring, and skin rejuvenation treatments — creating important research questions about efficacy, safety, patient selection, and the ethical dimensions of appearance-enhancement medicine in American dermatology practice. This category of dermatology thesis topics examines both the clinical science of cosmetic dermatological procedures and the psychosocial dimensions of appearance-enhancement seeking in American patients.

161. Investigating the patient-reported satisfaction and complication rates for hyaluronic acid filler volume replacement across different anatomical locations in American adults using a large-scale prospective registry
162. Analyzing the neurotoxin injection longevity and patient satisfaction comparison across abobotulinumtoxinA, onabotulinumtoxinA, and incobotulinumtoxinA formulations in American cosmetic dermatology practices
163. Developing a patient selection and contraindication screening protocol for cosmetic dermatological procedures in American practices and evaluating its effectiveness in reducing adverse events and psychological harm
164. Characterizing the radiofrequency microneedling effectiveness for skin laxity improvement and scar revision in American adults across different Fitzpatrick skin types using standardized photographic and ultrasound measurement
165. Investigating the thread lift procedure safety and longevity outcomes in American adults and evaluating the complication rates and patient satisfaction compared to surgical facelift alternatives
166. Analyzing the chemical peel — including glycolic acid, trichloroacetic acid, and phenol — comparative effectiveness for photoaging and dyspigmentation treatment in American adults across different skin types
167. Developing a cosmetic dermatology informed consent process evaluation for American practices and identifying the information adequacy and comprehension gaps most strongly associated with patient dissatisfaction
168. Characterizing the body contouring procedure — including cryolipolysis, high-intensity focused ultrasound, and radiofrequency — effectiveness and patient selection criteria in American cosmetic dermatology populations
169. Investigating the platelet-rich plasma and exosome therapy effectiveness for skin rejuvenation and hair loss treatment in American cosmetic dermatology practices using controlled clinical trial methodology
170. Analyzing the cosmetic dermatological procedure social media marketing practices and their relationship to patient expectation calibration and satisfaction outcomes in American practices

15. Emerging Frontiers in Dermatology

Emerging frontiers in dermatology encompass the most innovative research directions — including the cutaneous microbiome as a therapeutic target, gene therapy for genodermatoses, artificial intelligence for dermatological diagnosis, and the skin-gut-brain axis — creating a forward-looking category of dermatology thesis topics that engages graduate students with the discoveries defining the future of American dermatology practice and skin science.

171. Investigating the live biotherapeutic product skin microbiome restoration effectiveness for atopic dermatitis in American adults using Staphylococcus hominis A9 and evaluating its immune modulation mechanism
172. Analyzing the CRISPR gene editing approach for correcting dominant-negative KRT14 mutations causing epidermolysis bullosa simplex in patient-derived keratinocytes and evaluating its therapeutic potential
173. Developing a large language model clinical decision support tool for American dermatologists and evaluating its differential diagnosis accuracy for inflammatory, infectious, and neoplastic skin conditions
174. Characterizing the skin-gut axis bidirectional communication mechanisms and their relevance to inflammatory skin disease pathogenesis and probiotic intervention effectiveness in American patients
175. Investigating the wearable UV dosimeter effectiveness for real-time ultraviolet radiation exposure monitoring and sun protection behavior modification in American adults at high skin cancer risk
176. Analyzing the spatial transcriptomics approach for mapping cell type-specific gene expression patterns in atopic dermatitis and psoriasis lesional skin compared to non-lesional and healthy control skin
177. Developing a precision dermatology framework for American patients with psoriasis that integrates genomic, transcriptomic, and immunological biomarkers to predict biologic therapy response before treatment initiation
178. Characterizing the extracellular vesicle and exosome content patterns in American patients with atopic dermatitis, psoriasis, and melanoma as diagnostic and therapeutic biomarker candidates
179. Investigating the artificial intelligence model performance for predicting biologic therapy response from baseline clinical and biomarker features in American adults with moderate-to-severe psoriasis
180. Analyzing the microRNA expression patterns in melanoma-derived exosomes as liquid biopsy biomarkers for early metastasis detection in American melanoma patients under surveillance

16. Dermatoepidemiology and Population Skin Health

Dermatoepidemiology examines the distribution, determinants, and burden of skin disease across American populations — providing the epidemiological foundation for understanding which Americans are most affected by skin disease, what environmental and genetic factors drive skin disease risk, and how skin disease burden has changed over time across American communities.

181. Investigating the atopic dermatitis incidence trends and geographic variation across American states and evaluating the relationship between environmental factors and atopic disease prevalence changes
182. Analyzing the melanoma incidence trends by anatomical site, histological subtype, and demographic characteristics across American states using SEER registry data
183. Developing a population-based skin disease prevalence survey methodology for American communities using standardized examination protocols and evaluating its feasibility and epidemiological validity
184. Characterizing the skin disease burden attributable to ultraviolet radiation exposure in American adults using population-attributable fraction methodology and national melanoma and non-melanoma registry data
185. Investigating the relationship between socioeconomic deprivation and skin disease prevalence, severity, and treatment access in American adults using NHANES dermatological examination and socioeconomic data
186. Analyzing the occupational skin disease incidence trends across American industries using Bureau of Labor Statistics surveillance data and evaluating industry-specific prevention program effectiveness
187. Developing a geospatial skin cancer risk mapping tool for American counties that integrates ultraviolet index, tanning bed density, dermatologist access, and demographic risk factors for targeted prevention
188. Characterizing the psoriasis and atopic dermatitis comorbidity burden — including cardiovascular disease, metabolic syndrome, and depression — in American adults using population-based electronic health record cohort methodology
189. Investigating the skin disease quality of life burden using the Dermatology Life Quality Index across common inflammatory conditions in American adults and evaluating its relationship to treatment utilization
190. Analyzing the dermatophytosis — including tinea pedis, tinea cruris, and onychomycosis — prevalence and antifungal treatment patterns in American adults using NHANES physical examination and pharmacy claims data

17. Wound Care and Chronic Wounds

Chronic wounds — including diabetic foot ulcers, venous leg ulcers, pressure injuries, and non-healing surgical wounds — represent a significant and often underappreciated burden for American patients and health systems, with important research questions about wound biology, advanced wound care technologies, infection management, and the multidisciplinary care models needed to optimize healing outcomes for wound-care-dependent Americans.

191. Investigating the negative pressure wound therapy effectiveness for promoting healing in American adults with complex diabetic foot wounds and evaluating the predictors of treatment success and amputation prevention
192. Analyzing the bilayer wound matrix and cellular and tissue-based product comparative effectiveness for venous leg ulcer healing in American wound care clinic populations
193. Developing a multidisciplinary wound care program for American adults with non-healing diabetic foot ulcers incorporating vascular surgery, podiatry, infectious disease, and dermatology expertise
194. Characterizing the wound biofilm microbial composition and its relationship to chronic wound healing trajectory in American adults with diabetic foot ulcers using metagenomic sequencing methodology
195. Investigating the hyperbaric oxygen therapy effectiveness and appropriate patient selection criteria for chronic non-healing wounds in American adults with peripheral vascular disease and diabetes
196. Analyzing the pressure injury prevention bundle implementation effectiveness in American long-term care facilities and evaluating its relationship to pressure injury incidence and severity outcomes
197. Developing an artificial intelligence wound assessment tool using photographic wound imaging for objective wound area measurement and healing trajectory prediction in American wound care settings
198. Characterizing the social determinants of wound healing — including housing instability, food insecurity, and social support — and their relationship to chronic wound outcomes in American adults
199. Investigating the telemedicine wound monitoring program effectiveness for American adults with chronic wounds in home health settings and evaluating its impact on wound healing and unnecessary emergency department visits
200. Analyzing the wound care product cost-effectiveness and health economic value of advanced wound dressings versus standard of care in American Medicare wound care populations

The Range of Dermatology Thesis Topics

Current Issues

The biologic therapy revolution in inflammatory dermatology has fundamentally transformed outcomes for American patients with moderate-to-severe atopic dermatitis and psoriasis — with interleukin-4 and interleukin-13 receptor antagonists, interleukin-17 inhibitors, interleukin-23 inhibitors, and JAK inhibitors producing skin clearance rates and quality of life improvements that were unimaginable with conventional immunosuppressive therapy. Yet the extraordinary clinical effectiveness of these agents is accompanied by important unresolved research questions about treatment sequencing when initial biologics fail, long-term safety monitoring requirements, optimal therapy duration, and the criteria for treatment discontinuation in patients achieving sustained remission. Perhaps most urgently, the high cost of biologic dermatological therapies creates profound access disparities — with American patients with Medicaid coverage or no insurance facing dramatically higher barriers to biologic therapy than those with commercial insurance — generating a health equity crisis in inflammatory dermatology that demands urgent research attention. Graduate students developing dermatology thesis topics that address biologic therapy access, real-world effectiveness, and treatment optimization for American patients across insurance and socioeconomic groups contribute to some of the most practically consequential research questions in contemporary American dermatology.

Dermatological care access has reached a crisis point in the United States — with dermatology consistently ranking among the specialties with the longest appointment wait times in American healthcare, the geographic maldistribution of dermatologists concentrating the specialty in urban areas while rural and lower-income communities lack adequate access, and the dermatology workforce remaining among the least racially diverse in American medicine. The consequences of inadequate dermatology access are measurable — with later-stage melanoma diagnosis, undertreated inflammatory skin disease, and inadequate acne and eczema management contributing to preventable disability and disease progression among Americans who cannot access timely dermatological care. Research addressing teledermatology program effectiveness, primary care dermatology education, and workforce diversity pipeline programs contributes to the most equity-relevant research agenda in American dermatology.

Skin cancer prevention and early detection represent one of the most important public health opportunities in American dermatology — with melanoma remaining highly curable when detected early but potentially fatal when diagnosed at advanced stage, and with the determinants of timely diagnosis including access to full-body skin examination, patient awareness of warning signs, and primary care physician skin cancer recognition skill. The continuing rise in melanoma incidence among young American women from tanning bed use, the inadequate sunscreen use rates among American adolescents, and the persistent late-stage melanoma diagnosis disparities among American patients of color create a comprehensive skin cancer prevention research agenda spanning behavioral interventions, health system design, and the equitable implementation of skin cancer screening programs across diverse American communities.

Recent Trends

Artificial intelligence has entered dermatology as a diagnostic assistance technology with particular promise — given that dermatological diagnosis is fundamentally visual and that large archives of annotated clinical and dermoscopic photographs enable supervised learning at scales that produce impressive diagnostic accuracy. Deep learning systems for melanoma detection from dermoscopic images have demonstrated performance approaching or matching that of expert dermatologists in controlled research settings, and AI-assisted teledermatology platforms are beginning to be deployed in American primary care settings to improve the appropriateness of dermatology referrals. The research community is actively investigating the real-world clinical impact of AI-assisted dermatological diagnosis, the demographic performance disparities of AI systems trained predominantly on lighter skin tone images, and the appropriate integration of AI tools into American dermatological practice workflows. Graduate students developing dermatology thesis topics in AI-assisted diagnosis, fairness evaluation, and implementation science are working at one of the most practically relevant technical frontiers in contemporary American dermatology.

The skin microbiome has emerged as a central research focus in dermatology — with the recognition that the commensal bacterial communities inhabiting skin surfaces actively regulate cutaneous immunity, barrier function, and inflammatory responses in ways that shape susceptibility to conditions including atopic dermatitis, acne, and rosacea. American dermatology research programs are investigating how skin microbiome dysbiosis — particularly Staphylococcus aureus overgrowth — drives atopic dermatitis flares and inflammation, how commensal Staphylococcus epidermidis and other organisms promote skin barrier integrity and immune homeostasis, and how live biotherapeutic products based on skin commensal bacteria might restore microbiome balance as a novel therapeutic approach. The clinical translation of skin microbiome research into therapeutic products represents one of the most scientifically exciting and commercially active frontiers in American dermatology.

Future Directions

Gene therapy for genodermatoses — the inherited disorders of skin structure and function including epidermolysis bullosa, ichthyosis, and palmoplantar keratodermas — represents one of the most transformative therapeutic frontiers in American dermatology, with ex vivo gene-corrected skin grafting demonstrating proof of concept in human patients and in vivo gene editing approaches advancing through preclinical development. Future dermatology thesis topics will evaluate the extension of gene therapy approaches to additional genodermatoses, investigate the delivery vehicles and editing strategies best suited for reaching keratinocytes and dermal fibroblasts in vivo, address the long-term safety and durability of gene-corrected skin, and examine the equity implications of ensuring that highly complex and expensive gene therapies reach American children with genodermatoses regardless of their socioeconomic circumstances or geographic proximity to centers capable of delivering these treatments. The prospect of curative genetic intervention for conditions that have caused lifelong disability and suffering for American patients represents one of the most compelling future directions in dermatological research.

Precision dermatology — the integration of genomic, transcriptomic, immunological, and microbiome biomarkers to individualize treatment selection and predict treatment response — represents a second transformative future direction that will move American dermatological practice beyond current trial-and-error approaches to biologic therapy selection toward evidence-based personalized treatment matching. Future dermatology thesis topics will develop and validate biomarker panels that predict which American patients with psoriasis or atopic dermatitis will respond to which specific biologic mechanism, investigate the machine learning approaches for integrating multiple biomarker types into clinically implementable treatment prediction tools, and address the equity challenges of ensuring that precision dermatology benefits are available to American patients across diverse socioeconomic backgrounds and practice settings. Graduate students who combine dermatological science expertise with genomics and computational skills will be uniquely positioned to contribute to this precision dermatology research agenda.

Conclusion

The 200 dermatology thesis topics presented across these seventeen categories reflect the extraordinary breadth of a discipline that spans inflammatory skin diseases and skin cancer, autoimmune blistering conditions and acne, hair and nail disorders and pediatric dermatology, dermatological health disparities and surgical dermatology, teledermatology and digital skin health, dermatopharmacology and skin microbiome, psychodermatology and occupational dermatology, cosmetic dermatology and emerging therapeutic frontiers, wound care and population skin health. Students pursuing dermatology thesis topics at American universities engage with research questions that span molecular immunology and epidemiology, clinical pharmacology and health services research, technology innovation and health equity — questions whose answers will determine whether the extraordinary therapeutic advances in biologic dermatology reach all Americans equitably, whether skin cancer prevention programs succeed in reversing rising incidence trends, and whether the next generation of American dermatology practice is more precise, more accessible, and more representative of the diverse patients it serves. Career pathways extend into academic dermatology, pharmaceutical dermatology drug development, medical device industry, health policy, global skin health, and the technology companies developing AI-assisted dermatological diagnostics — all domains where rigorously trained dermatology scholars make lasting contributions to improving skin health across American and global populations.

Academic Support

iResearchNet provides expert academic support for graduate students developing dermatology thesis topics across the full spectrum of this discipline’s biological, clinical, epidemiological, and health policy dimensions. Our consultants bring specialized expertise in inflammatory skin diseases, skin cancer and melanoma, autoimmune dermatology, acne and rosacea, hair and nail disorders, pediatric dermatology, dermatological health disparities, dermatological surgery, teledermatology and digital skin health, dermatopharmacology, skin microbiome, psychodermatology, occupational dermatology, cosmetic dermatology, wound care, and emerging dermatological frontiers — with direct experience supporting students in American dermatology residency research programs, skin biology doctoral training, clinical research fellowships, and health services research programs focused on dermatological care quality and equity. Whether you are designing a biologic therapy randomized trial, analyzing skin cancer registry data, developing a teledermatology implementation evaluation, building a health disparities research program focused on skin disease, or investigating the mechanisms of skin inflammation in a laboratory-based thesis project, iResearchNet’s support is oriented toward strengthening your scholarly development and deepening your engagement with dermatology as a research discipline. Our mission is to support your intellectual growth, not to substitute for the original thinking that defines excellent graduate scholarship in dermatology.